Status:
COMPLETED
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
Abbott Diabetes Care
Conditions:
Diabetes
Glucose Variability
Eligibility:
All Genders
21+ years
Brief Summary
The purpose of this study is to obtain sufficient continuous glucose monitoring (CGM) data in a manner that provides clinical information that is not available using conventional self-monitored blood ...
Detailed Description
There are two purposes to the study. First, to use an investigational device, the FreeStyle Navigator Continuous Glucose Monitoring (CGM) System (Abbott Diabetes Care) to obtain sufficient longitudina...
Eligibility Criteria
Inclusion
- Male or female
- Diagnosed with type 1 or type 2 diabetes
- Treated with insulin therapy
- Can also be taking other diabetes medication treatment
- Age 21 and older
- Willing to give informed consent
- Capable of following the protocol and instructions of study staff
- Available for scheduled visits
- Access to telephone communications
Exclusion
- Under 21 years of age
- Unable to follow protocol
- Unable to read and write in English
- Skin abnormalities at insertion sites
- Allergy to adhesives
- Any concomitant medication thay would likely affect evaluation of device
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
April 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00465881
Start Date
January 1 2006
End Date
April 1 2006
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Diabetes Center - Park Nicollet Health Services
Minneapolis, Minnesota, United States, 55416